The SFT or BIA method would be preferred to monitor BCA in non-obese subjects in clinical routine. However, DEXA should be considered as the method of choice in obese patient monitoring, since reproducibility gains special importance, other than the accuracy in the context.
No takes yet. Share an insight, caveat, or question.
Erselcan et al. (2000) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: